Can a patient with a history of triple coronary artery bypass surgery who is taking daily low‑dose (baby) aspirin safely hold the aspirin for one week before a cosmetic procedure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Should Aspirin Be Held for One Week Before a Cosmetic Procedure in a Post-CABG Patient?

No, aspirin should generally NOT be stopped for a full week before a cosmetic procedure in a patient with prior coronary artery bypass surgery—the cardiovascular risks of aspirin withdrawal typically outweigh the bleeding risks for most procedures.

Key Recommendation

Continue aspirin perioperatively unless the cosmetic procedure carries exceptionally high bleeding risk (such as intracranial surgery). 1 The ACC/AHA guidelines explicitly state that "monotherapy with aspirin need not be routinely discontinued for elective noncardiac surgery" and that "aspirin should only be discontinued if the known bleeding risks are similar or more severe than the observed cardiovascular risks of aspirin withdrawal." 1

Clinical Reasoning

Why Continuing Aspirin Is Preferred

  • Post-CABG patients have specific indications for lifelong aspirin: The ACC/AHA CABG guidelines state that "aspirin is the drug of choice for prophylaxis against early saphenous graft thrombotic closure" and "should be continued indefinitely, given its benefit in the secondary prevention of subsequent clinical events." 1

  • Cardiovascular risk of stopping aspirin: In patients with established coronary disease (like your post-CABG patient), aspirin withdrawal increases thrombotic complications including MI, stroke, and graft thrombosis 1

  • Bleeding risk is manageable: Low-dose aspirin increases the frequency of procedural bleeding (relative risk 1.5) but does NOT increase the severity of bleeding complications or perioperative mortality in most surgeries 1

The Evidence on Bleeding

The POISE-2 trial 2 showed that aspirin increased major bleeding (4.6% vs 3.8%) but this must be weighed against cardiovascular protection. Importantly, most cosmetic procedures have lower bleeding risk than the surgeries studied in major trials.

Special Considerations for Cosmetic Procedures

Most cosmetic procedures (facelifts, rhinoplasty, liposuction, breast augmentation) do NOT fall into the high-risk bleeding category. The guidelines identify only two specific exceptions where aspirin discontinuation may be warranted:

  • Intracranial surgery
  • Prostatectomy 1

Your cosmetic procedure likely does not meet this threshold.

Practical Management Algorithm

If Aspirin MUST Be Stopped (High-Risk Bleeding Procedure Only):

  1. Minimize discontinuation time: Stop aspirin no more than 5-7 days before surgery (NOT a full week) 1
  2. Resume immediately: Restart aspirin as soon as hemostasis is achieved postoperatively, ideally within 24-48 hours 1, 3
  3. Never stop for more than necessary: The longer aspirin is held, the higher the cardiovascular risk

If Continuing Aspirin (Recommended for Most Cases):

  1. Maintain 75-100 mg daily throughout the perioperative period 3, 4
  2. Coordinate with surgeon: Ensure surgical team is comfortable with meticulous hemostasis techniques
  3. Optimize surgical technique: Use electrocautery, local hemostatic agents, and careful tissue handling

Critical Pitfalls to Avoid

⚠️ Do NOT routinely stop aspirin for cosmetic procedures - The default should be continuation unless there's a compelling bleeding risk

⚠️ Do NOT stop aspirin "just to be safe" - This paradoxically increases risk in cardiovascular patients

⚠️ Do NOT extend discontinuation beyond what's absolutely necessary - Every extra day off aspirin increases thrombotic risk

⚠️ Do NOT forget to document the risk-benefit discussion - If aspirin is stopped, clearly document why the bleeding risk outweighs cardiovascular risk

The Bottom Line

For a patient with triple bypass on daily aspirin, continue the aspirin through the cosmetic procedure unless the surgeon can provide specific evidence that this particular procedure has bleeding risks equivalent to intracranial surgery or prostatectomy. 1 The 2024 AHA/ACC guidelines reinforce that in patients with prior coronary disease, "it is recommended to continue aspirin (75-100 mg), if possible, to reduce the risk of cardiac events." 4

If the cosmetic surgeon insists on stopping aspirin, limit discontinuation to 5-7 days maximum (not a full week), and restart immediately postoperatively. 1, 3

Related Questions

For an adult patient with documented coronary artery disease, what is the appropriate aspirin (acetylsalicylic acid) therapy regimen?
Is aspirin (acetylsalicylic acid) indicated for adults with non‑obstructive coronary artery disease?
Why should aspirin be stopped five days before coronary artery bypass grafting (CABG) but continued for percutaneous coronary intervention (angioplasty)?
Is low‑dose aspirin (81 mg daily) safer than clopidogrel (Plavix, 75 mg daily) for a patient requiring frequent large‑volume paracentesis?
For a patient who has undergone triple coronary artery bypass grafting with atrial clip placement, should low‑dose aspirin (81 mg daily) be started, and what are the appropriate timing, duration, and alternatives if aspirin is not tolerated?
What is the optimal peri‑operative anticoagulation and antiplatelet management for a patient undergoing triple coronary artery bypass grafting (CABG) with an atrial appendage clip?
What is a direct oral anticoagulant (DOAC)?
What are the appropriate anti‑coma measures and management steps for a patient presenting with coma?
In a patient with hyperferritinemia, MRSA‑related abscess, severe cellulitis of the left leg extending to the pelvis, and tachycardia, what is the likely cause of the elevated ferritin?
What is the appropriate dose and infusion protocol for Monofer (iron carboxymaltose) in an adult with iron‑deficiency anemia, considering the patient's hemoglobin level?
What does aspirin cardiovascular withdrawal refer to?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.